Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma CLINICAL CANCER RESEARCH Ramchandren, R., Advani, R. H., Ansell, S. M., Bartlett, N. L., Chen, R., Connors, J. M., Feldman, T., Forero-Torres, A., Friedberg, J. W., Gopal, A. K., Gordon, L. I., Kuruvilla, J., Savage, K. J., Younes, A., Engley, G., Manley, T. J., Fenton, K., Straus, D. J. 2019; 25 (6): 1718–26

View details for DOI 10.1158/1078-0432.CCR-18-2435

View details for Web of Science ID 000461476000006